| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Health Care sector is very positive (overall 2.6, positive 3.3, negative -0.7) on 20251018. The forces of Sentiment towards Fundamentals (2.5), Price Level (2), Option Speculation (1.5), Broad Market Trend (0.5), and Sector Price Trend (-0.3) will drive up the price. The forces of Valuation Sentiment (-1), and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3.3). The extreme bullish overall sentiment (2.6) may signal the top of this uptrend. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-18 | 0% | 1.1% | 1.5 | 0 | 2.5 | 8 | ||||
| 2025-10-17 | 2% | 1.3% | 143.24 | 67 | 0.64% | -0.07% | 1.3 | 0 | 2.2 | 2.7 |
| 2025-10-16 | 1% | 1.1% | 142.33 | 62 | -0.17% | -0.07% | 0.7 | -0.2 | 2.2 | 4 |
| 2025-10-15 | 2% | 1% | 142.57 | 66 | 0.17% | -0.07% | 0.8 | -0.3 | 2.2 | 4 |
| 2025-10-14 | 2% | 0.9% | 142.33 | 66 | 0.27% | 0.21% | 0.7 | -0.4 | 2.3 | 5.8 |
| 2025-10-13 | 0% | 0.9% | 141.94 | 65 | -0.13% | 0.42% | 0.5 | -0.3 | 2.1 | 4 |
| 2025-10-12 | 1% | 1% | 1.5 | 0.4 | 2.4 | -4 | ||||
| 2025-10-11 | 1% | 0.9% | 1.4 | 0.4 | 2.3 | 5 | ||||
| 2025-10-10 | 1% | 0.9% | 142.12 | 67 | -1.46% | 0.49% | 1.5 | 0.4 | 2.4 | 1.6 |
| 2025-10-09 | 0% | 1% | 144.23 | 84 | -0.17% | 0.71% | 2.1 | 1 | 2.4 | 8 |
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (8) AI Startup WellTheory Raises $14 Million From General Catalyst, Accel, 7wire Ventures To Transform Autoimmune Health For Millions Of Patients WellTheory, a female-founded health technology startup utilizing artificial intelligence to transform autoimmune care, announced Tuesday that it secured $14 million in Series A funding. The round was led by General Catalyst, with participation from ... (https://finance.yahoo.com/) Sat. Oct 18, 2025 | |
| 2 (6) Blackstone, TPG Near Hologic Deal for More Than $17 Billion Blackstone Inc. and TPG Inc. are in advanced negotiations to acquire Hologic Inc. in a deal that could value the medical device maker at more than $17 billion including debt, according to people familiar with the matter. (https://www.bloomberg.com/) Fri. Oct 17, 2025 | |
| 3 (-5) Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s Eli Lilly and Novo Nordisk shares dropped after President Donald Trump said he wants a $150 price tag for GLP-1s. (https://www.cnbc.com/) Fri. Oct 17, 2025 | |
| 4 (8) Humana Inc. stock outperforms competitors on strong trading day Shares of Humana Inc. HUM rose 2.89% to $275.01 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to 6,664.01 and the Dow Jones Industrial Average DJIA rising 0.52% to 46,190.61. This was the stock's third consecutive day of gains. (https://www.marketwatch.com/) Fri. Oct 17, 2025 | |
| 5 (8) Gilead Sciences Inc. stock outperforms competitors on strong trading day Shares of Gilead Sciences Inc. GILD rose 4.21% to $122.81 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to 6,664.01 and the Dow Jones Industrial Average DJIA rising 0.52% to 46,190.61. The stock's rise snapped a two-day losing streak. (https://www.marketwatch.com/) Fri. Oct 17, 2025 | |
| 6 (7) Abbott Laboratories' October Price Plunge Is a Signal to Buy Abbott Laboratories is on track to reach new highs, potentially by early 2026, opening the door for a 30% stock price increase in addition to the dividend. (https://www.marketbeat.com/) Fri. Oct 17, 2025 | |
| 7 (-6) Here's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly Stocks President Trump said he would lower the prices of popular weight-loss drugs, pressuring shares of drugmakers Novo Nordisk and Eli Lilly Friday. (https://www.investopedia.com/) Fri. Oct 17, 2025 | |
| 8 (7) Boston Scientific To Buy Nalu Medical For Upfront $533 Mln Cash Boston Scientific Corporation (BSX), a medical technology company, said on Friday that it has inked a deal to acquire Nalu Medical, Inc., a privately held medical technology firm, for an upfront cash payment of around $533 million. (https://www.rttnews.com/) Fri. Oct 17, 2025 | |
| 9 (9) Sight Sciences Shares Jump 32% On Medicare Pricing Update For TearCare System Sight Sciences, Inc. (SGHT) shares rose 32.53 percent to $4.56, up $1.11 on Friday after announcing that Medicare Administrative Contractors Novitas Solutions and First Coast Service Options established jurisdiction-wide pricing for CPT code 0563T, which covers procedures performed using the company's TearCare System. (https://www.rttnews.com/) Fri. Oct 17, 2025 | |
| 10 (8) Make sure you own this high-quality MedTech stock: RBC Make sure you own this high-quality MedTech stock: RBC (https://www.investing.com/) Fri. Oct 17, 2025 | |
| 11 (-5) Medicare Part D plans: Expert reveals that 95% of beneficiaries are overspending on prescriptions Nearly all 55 million Medicare users overpay for prescriptions. Expert Katy Votava explains how to compare Part D plans and save thousands. (https://finance.yahoo.com/) Fri. Oct 17, 2025 | |
| 12 (7) Trump-Induced Volatility Aside, Novo Trades Cheap While Patents Protect Its Profits Until 2032 Novo Nordisk offers cheap stock with strong moat and long-term growth tailwinds. Trump's drug price cut suggestion caused short-term volatility but... (https://www.benzinga.com/) Fri. Oct 17, 2025 | |
| 13 (0) Stock Of The Day: Has United Health Found A New Trading Range? UnitedHealth Group (UNH) is in a trading range. Some traders will buy near the bottom and sell close to the top. (https://www.benzinga.com/) Fri. Oct 17, 2025 | |
| 14 (7) How Two Ride-Share Guys And An ER Doc Are Building An Air Traffic Control System For Healthcare Startup Sage Care is coming out of stealth with $20 million in funding and customers that include Bronson Healthcare and White Plains Hospital. (https://www.forbes.com/) Fri. Oct 17, 2025 | |
| 15 (-5) Novo, Lilly Fall as Trump Touts ‘Much Lower’ Ozempic Price The US list price of Ozempic, which Trump called “the fat loss drug,” is roughly $1,000 for a month’s supply. Trump told reporters on Thursday that the cost of the drug, made by Novo, will soon be “much lower.” Lilly sells similar treatments, including Mounjaro and Zepbound. (https://finance.yahoo.com/) Fri. Oct 17, 2025 | |
| 16 (-5) Weight-loss drug stocks are tumbling after Trump promised their costs ‘will be much lower’ President Trump is skeptical about the efficacy of weight-loss drugs and wants to lower the prices. (https://www.marketwatch.com/) Fri. Oct 17, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA